We sold our Emerging Healthcare Viking Therapeutics Position at $69: The company’s phase 2 data was released showing much better than expected results of13% weight loss after just 13 weeks of treatment. This is much better than anything on the market. The stock responded appropriately! This has been a very lucrative investment for our portfolios.

‍